Who owns PFEWhat PFE owns
What PFIZER INC owns
The company's own 13F portfolio · as of 2026-06-30 · long US-listed stakes only — private holdings, bonds and cash are not disclosable on a 13F
$170.4M
disclosed stock portfolio
17
positions
27.5%
in ALLO
Positions, as of 2026-06-30
ordered by filed value · % of book = share of the disclosed stock portfolio · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | ALLOALLOGENE THERAPEUTICS INC | 22.0M | $46.9M | 27.5% |
| 2 | CELCCELCUITY INC | 295,652 | $29.6M | 17.3% |
| 3 | ARVNARVINAS INC | 3.5M | $27.7M | 16.2% |
| 4 | PYXSPYXIS ONCOLOGY INC | 7.0M | $19.5M | 11.4% |
| 5 | WVEWAVE LIFE SCIENCES LTD | 1.9M | $10.9M | 6.4% |
| 6 | BHVNBIOHAVEN LTD | 505,645 | $8.0M | 4.7% |
| 7 | CRBUCARIBOU BIOSCIENCES INC | 4.7M | $7.9M | 4.6% |
| 8 | SPROSPERO THERAPEUTICS INC | 2.4M | $5.3M | 3.1% |
| 9 | ZNTLZENTALIS PHARMACEUTICALS INC | 953,834 | $3.9M | 2.3% |
| 10 | ORICORIC PHARMACEUTICALS INC | 372,904 | $3.6M | 2.1% |
| 11 | CRDFCARDIFF ONCOLOGY INC | 2.4M | $3.0M | 1.8% |
| 12 | ZURAZURA BIO LTD | 538,841 | $2.9M | 1.7% |
| 13 | AGMBAGOMAB THERAPEUTICS NV | 75,000 | $1.0M | 0.6% |
| 14 | BOLTBOLT BIOTHERAPEUTICS INC | 31,305 | $133,832 | 0.1% |
| 15 | NXTCNEXTCURE INC | 44,347 | $72,967 | 0% |
| 16 | DNAGINKGO BIOWORKS HOLDINGS INC | 2,928 | $30,012 | 0% |
| 17 | SENS1GBPSENSEONICS HLDGS INC | 2,171 | $12,418 | 0% |
Source: SEC Form 13F-HR filed by Pfizer Inc (CIK 78003), reporting period 2026-06-30. Values are quarter-end filed marks. Research, not investment advice.